Aortic valve replacement registry for people in Northeast China
Part of Heart & circulation clinical trials.
This study is a real-world registry that collects health information from people getting a less-invasive aortic valve replacement through a catheter (a “transcatheter” valve). It helps doctors understand outcomes and complications in everyday care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe aortic valve narrowing (stenosis), based on heart ultrasound measurements and/or stress/exercise test results.
- You plan to receive (or already received) a transcatheter aortic valve replacement using the study’s valve system.
- You can legally join the study and complete follow-up, and someone can contact you (or a legal guardian/relative can).
- You are not allergic to key needed medicines or materials (including common blood thinners like aspirin/heparin/bivalirudin and stent/valve material such as nickel-titanium).
- You are not pregnant or breastfeeding, and your valve/entry measurements fit: the aortic valve opening is 17–32 mm and the access blood vessel is at least 5 mm.
- You are not currently in another drug or device research study, and your doctor agrees you can safely participate and be followed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how safe and effective an emergency heart valve replacement is for people with severe aortic stenosis who are in critical condition. It may help if you have severe symptoms like shock or unstable chest pain that need urgent treatment.
This study tracks patients with severe aortic stenosis who receive the Myval transcatheter heart valve during TAVR (a less-invasive valve replacement). It aims to understand how well the valve works over time.
This study records results of a minimally invasive procedure to replace a narrowed or leaking heart valve. It may help doctors understand how well the treatment works and what complications happen in Chinese patients.
This study tracks patients getting a new heart valve (transcatheter aortic valve implantation) for severe aortic stenosis. It aims to understand long-term outcomes and safety in a real-world registry.
This trial tests a new valve device placed through a small tube (catheter) to treat severe aortic stenosis, a condition where the aortic valve is narrowed and doesn't open fully. It's for patients who cannot have traditional open-heart surgery.
This study follows adults who are having aortic valve replacement to better understand outcomes across different hospitals in Europe. It may help your care team compare results and improve future treatment planning.
Hear when a new Severe Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.